Trial Profile
Proleukin [aldesleukin] in combination with Rituxan [rituximab] in patients with low-grade non-Hodgkin's lymphoma who have previously failed Rituxan treatments
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Aldesleukin (Primary) ; Rituximab (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 22 Sep 2005 New trial record.